The cell harvesting market has seen considerable growth due to a variety of factors.
• In recent times, there has been significant growth in the size of the cell harvesting market. The market is expected to expand from $10.84 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.6%. The rise observed in the historic period can be associated with factors such as the growing occurrence of chronic diseases, increased levels of investment in research and development, and the broadening scope of regenerative medicine applications.
The Cell Harvesting market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for cell harvesting is anticipated to experience robust expansion in the coming years. It is projected to reach up to $15.34 billion in the year 2029, increasing at a compound annual growth rate (CAGR) of 7.4%.
The growth can be associated with a rising number of disease cases, trends of an aging population, expanding utilities in therapeutics, and strategic affiliations. The prediction period may witness significant trends such as technological progress, innovative products, regulatory orientation, market rivalry, and expansion of the global market.
The escalation in chronic disease cases is set to drive the expansion of the cell harvesting market. Chronic diseases are those long-term health issues that persist for a year or more, requiring ongoing medical attention, restricting daily activities, or both. Increased chronic diseases necessitate further research for discovering innovative treatments involving cell harvesting procedures for drug development. For instance, research released by the American Cancer Society, a health organization based in the US, in January 2022, predicts 609,360 cancer deaths and 1.9 million new cancer cases in the US during 2022, amounting to roughly 1,670 deaths daily. As such, the surge in chronic disease incidents propels the growth of the cell harvesting market.
The cell harvesting market covered in this report is segmented –
1) By Type: Manual Cell Harvesters, Automated Cell Harvesters
2) By Distribution Channel: Retail, Direct Tenders
3) By End-Users: Biotechnology And Biopharmaceutical Companies, Research Institute, Other End-Users
Subsegments:
1) By Manual Cell Harvesters: Syringe-Based Harvesters, Centrifuge-Based Harvesters, Filtration Devices
2) By Automated Cell Harvesters: Robotic Cell Harvesting Systems, Automated Centrifuges, Microfluidic Harvesting Devices
The cell harvesting market is noticeably influenced by the surge of technological innovations, a predominant trend being recognised recently. Numerous key players are striving to formulate novel technologies to consolidate their standing in the market. Thermo Fisher Scientific Inc., a US firm specializing in scientific manufacturing, launched the DynaSpin Single-Use Centrifuge System that utilizes the DynaSpin technology in September 2022. This innovation was crafted particularly to facilitate an optimal single-use solution for enlarged cell culture collection and provide centrifugation for cell harvesting. The DynaSpin system aids biological manufacturers in accomplishing their sustainability goals whilst reducing total production expenses. The apparatus allows up to a six-fold reduction in material usage and curtails waste by 70% compared to traditional harvest systems, as it decreases the quantity of filters necessary for harvesting during biologics production.
Major companies operating in the cell harvesting market include:
• PerkinElmer Inc.
• Connectorate AG
• Sartorius AG
• Terumo Corporation
• Cox Scientific Ltd.
• AVITA Medical Inc.
• Tomtec Inc.
• Teleflex Incorporated
• Arthrex Inc.
• Antylia Scientific
• Danaher Corporation
• Bertin Technologies Group
• Merck & Co. Inc.
• Eurofins Scientific SE
• Agilent Technologies Inc.
• Pall Corporation
• Thermo Fisher Scientific Inc.
• Scinomix Inc.
• Brandel Co.
• ADSTEC Corporation
• Thomas Scientific Inc.
• Miltenyi Biotec Technology & Trading Co. Ltd.
• Terumo BCT Inc.
• Bertin Pharma SAS
• GE Healthcare
• Argos Technologies Inc.
• Esco Lifesciences Group
• ReproCell Inc.
• CESCO Bioengineering Co. Ltd.
North America was the largest region in the cell harvesting market share in 2024. The regions covered in the cell harvesting market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.